Dimensional Fund Advisors LP lifted its position in Castlight Health Inc (NYSE:CSLT) by 93.8% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 263,904 shares of the software maker’s stock after purchasing an additional 127,761 shares during the quarter. Dimensional Fund Advisors LP’s holdings in Castlight Health were worth $1,122,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also recently made changes to their positions in the company. BlackRock Inc. boosted its position in shares of Castlight Health by 30.4% in the 2nd quarter. BlackRock Inc. now owns 4,637,348 shares of the software maker’s stock valued at $19,710,000 after purchasing an additional 1,081,140 shares during the period. Russell Investments Group Ltd. acquired a new stake in shares of Castlight Health in the 2nd quarter valued at about $2,315,000. Allianz Asset Management GmbH acquired a new stake in shares of Castlight Health in the 1st quarter valued at about $180,000. Gagnon Advisors LLC boosted its position in shares of Castlight Health by 29.7% in the 2nd quarter. Gagnon Advisors LLC now owns 1,169,056 shares of the software maker’s stock valued at $4,968,000 after purchasing an additional 267,662 shares during the period. Finally, Schwab Charles Investment Management Inc. raised its stake in Castlight Health by 34.8% during the 2nd quarter. Schwab Charles Investment Management Inc. now owns 365,590 shares of the software maker’s stock valued at $1,554,000 after acquiring an additional 94,310 shares during the last quarter. 50.05% of the stock is owned by hedge funds and other institutional investors.
CSLT opened at $2.30 on Tuesday. The company has a quick ratio of 1.85, a current ratio of 1.85 and a debt-to-equity ratio of 0.02. The company has a market cap of $326.49 million, a price-to-earnings ratio of -8.85 and a beta of 1.15. Castlight Health Inc has a 52 week low of $2.20 and a 52 week high of $5.95.
Several analysts have commented on the company. William Blair reaffirmed a “buy” rating on shares of Castlight Health in a research note on Thursday, October 18th. Zacks Investment Research raised Castlight Health from a “hold” rating to a “buy” rating and set a $5.00 price objective for the company in a research note on Wednesday, July 11th. Canaccord Genuity reduced their price objective on Castlight Health from $7.00 to $6.00 and set a “buy” rating for the company in a research note on Tuesday, July 31st. Dougherty & Co upped their price objective on Castlight Health from $6.00 to $7.00 and gave the company a “buy” rating in a research note on Monday, July 23rd. Finally, Cantor Fitzgerald reaffirmed a “buy” rating and set a $5.00 price objective on shares of Castlight Health in a research note on Friday, August 17th. One analyst has rated the stock with a sell rating, two have issued a hold rating and five have assigned a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and a consensus target price of $5.56.
Castlight Health Company Profile
Castlight Health, Inc provides a software-as-a-service platform used for health benefits navigation for employees in the United States. Its platform matches employees to the resources their employers make available to them; managing a condition; and assists them to manage their benefits. The company also offers communication and testing, implementation, and user customer support services.
See Also: How Do You Make Money With Penny Stocks?
Want to see what other hedge funds are holding CSLT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Castlight Health Inc (NYSE:CSLT).
Receive News & Ratings for Castlight Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castlight Health and related companies with MarketBeat.com's FREE daily email newsletter.